Nova Eye Medical Limited (ASX:EYE)
Australia · Delayed Price · Currency is AUD 0.1550
+0.0050 (3.33%)
Aug 7, 2026, 2:49 PM AEST
Nova Eye Medical Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 2.62 | 5.06 | 6.15 | 7.42 | 8 | 17.8 |
Cash & Short-Term Investments | 2.62 | 5.06 | 6.15 | 7.42 | 8 | 17.8 |
Cash Growth | -48.11% | -17.82% | -17.09% | -7.26% | -55.06% | -81.39% |
Accounts Receivable | 4.1 | 4.09 | 3.9 | 1.93 | 2.05 | 1.91 |
Other Receivables | - | 0.09 | 0.18 | 1.18 | 1.72 | 3.52 |
Receivables | 4.1 | 4.18 | 4.08 | 3.11 | 3.77 | 5.43 |
Inventory | 3.5 | 2.81 | 4.28 | 3.81 | 3.54 | 2.9 |
Prepaid Expenses | 0.34 | 0.27 | 0.23 | 0.27 | 0.28 | 0.2 |
Total Current Assets | 10.55 | 12.33 | 14.75 | 14.6 | 15.59 | 26.33 |
Property, Plant & Equipment | 3.12 | 3.36 | 3.9 | 2.36 | 2.95 | 3.51 |
Other Intangible Assets | 6.39 | 6.86 | 7.03 | 8.45 | 7.17 | 3.44 |
Long-Term Deferred Charges | 3.54 | 3.89 | 4.13 | 4.87 | 10.85 | 8.66 |
Other Long-Term Assets | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 |
Total Assets | 23.67 | 26.5 | 29.88 | 30.36 | 36.63 | 41.99 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 2.58 | 2.35 | 3.57 | 4.31 | 2.41 | 2 |
Accrued Expenses | - | 2.17 | 1.64 | 1.32 | 0.91 | 0.74 |
Current Portion of Long-Term Debt | - | - | - | - | - | 1.42 |
Current Portion of Leases | 0.65 | 0.63 | 0.48 | 0.64 | 0.54 | 0.52 |
Other Current Liabilities | 2.47 | - | - | 0.01 | 0.01 | 0 |
Total Current Liabilities | 5.7 | 5.15 | 5.68 | 6.27 | 3.86 | 4.69 |
Long-Term Leases | 2.15 | 2.38 | 2.87 | 0.89 | 1.4 | 1.76 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.97 | 0.14 |
Other Long-Term Liabilities | - | - | - | - | - | 0.08 |
Total Liabilities | 7.85 | 7.54 | 8.55 | 7.17 | 6.23 | 6.66 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 59.1 | 58.94 | 52.71 | 45.18 | 37.44 | 36.68 |
Retained Earnings | -43.11 | -39.75 | -30.69 | -21.9 | -6.6 | 0.89 |
Comprehensive Income & Other | -0.16 | -0.23 | -0.69 | -0.09 | -0.44 | -2.24 |
Shareholders' Equity | 15.82 | 18.97 | 21.33 | 23.19 | 30.4 | 35.34 |
Total Liabilities & Equity | 23.67 | 26.5 | 29.88 | 30.36 | 36.63 | 41.99 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 2.79 | 3.02 | 3.35 | 1.53 | 1.94 | 3.7 |
Net Cash (Debt) | -0.17 | 2.04 | 2.8 | 5.89 | 6.06 | 14.1 |
Net Cash Growth | - | -27.27% | -52.41% | -2.79% | -57.05% | -84.72% |
Net Cash Per Share | -0.00 | 0.01 | 0.01 | 0.04 | 0.04 | 0.10 |
Filing Date Shares Outstanding | 285.17 | 284.71 | 229.06 | 190.33 | 145.58 | 143.69 |
Total Common Shares Outstanding | 285.17 | 284.15 | 228.82 | 190.33 | 145.58 | 143.69 |
Working Capital | 4.85 | 7.17 | 9.07 | 8.33 | 11.73 | 21.64 |
Book Value Per Share | 0.06 | 0.07 | 0.09 | 0.12 | 0.21 | 0.25 |
Tangible Book Value | 9.43 | 12.11 | 14.3 | 14.74 | 23.22 | 31.89 |
Tangible Book Value Per Share | 0.03 | 0.04 | 0.06 | 0.08 | 0.16 | 0.22 |
Machinery | - | 3.48 | 3.07 | 2.96 | 2.56 | 2.32 |